Millennium Management’s Neos Therapeutics, Inc NEOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-15,770
Closed -$8 5794
2020
Q3
$8 Sell
15,770
-344
-2% -$234 ﹤0.01% 4378
2020
Q2
$11K Sell
16,114
-36,016
-69% -$28.6K ﹤0.01% 4108
2020
Q1
$39K Buy
52,130
+23,211
+80% +$31.9K ﹤0.01% 3687
2019
Q4
$44K Sell
28,919
-11,761
-29% -$17.6K ﹤0.01% 4105
2019
Q3
$60K Sell
40,680
-404,359
-91% -$654K ﹤0.01% 4032
2019
Q2
$574K Buy
445,039
+121,215
+37% +$223K ﹤0.01% 3131
2019
Q1
$845K Buy
323,824
+235,181
+265% +$552K ﹤0.01% 2967
2018
Q4
$146K Buy
88,643
+17,927
+25% +$50.3K ﹤0.01% 3476
2018
Q3
$343K Sell
70,716
-99,329
-58% -$563K ﹤0.01% 3420
2018
Q2
$1.06M Buy
170,045
+107,515
+172% +$802K ﹤0.01% 2800
2018
Q1
$519K Buy
+62,530
New +$597K ﹤0.01% 3005
2017
Q4
Sell
-1,068,725
Closed -$9.78M 4209
2017
Q3
$9.78M Buy
1,068,725
+475,447
+80% +$3.61M 0.01% 1263
2017
Q2
$4.33M Buy
593,278
+42,410
+8% +$320K 0.01% 1604
2017
Q1
$3.97M Buy
550,868
+254,693
+86% +$1.58M 0.01% 1590
2016
Q4
$1.73M Sell
296,175
-3,825
-1% -$25.9K ﹤0.01% 1957
2016
Q3
$1.97M Buy
+300,000
New +$2.38M ﹤0.01% 1940
2015
Q4
Sell
-13,628
Closed -$286K 3901
2015
Q3
$286K Buy
+13,628
New +$300K ﹤0.01% 2934

Other funds holding NEOS

Millennium Management's NEOS Position: Q4 2020 in Review

Millennium Management sold out of Neos Therapeutics, Inc (NEOS) in Q4 2020, closing a stake of 15,770 shares — an estimated $8 sold.

Millennium Management first reported a position in NEOS in Q3 2015 and held it in 17 quarters. The position peaked at $9.78M in Q3 2017. 37 funds tracked by Wall St. Rank hold NEOS as of Q4 2020.

  • Millennium Management reported no remaining Neos Therapeutics, Inc position as of Q4 2020 after selling out during the quarter.
  • Millennium Management sold 15,770 Neos Therapeutics, Inc shares in Q4 2020, an estimated $8.
  • Millennium Management first reported a position in Neos Therapeutics, Inc in Q3 2015 and held it in 17 quarters.
  • Millennium Management's Neos Therapeutics, Inc position peaked at $9.78M in Q3 2017.
  • 37 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2020.

Based on Millennium Management's 13F filing for Q4 2020, filed 16 Feb 2021.